Literature DB >> 12089090

Amblyopia treatment outcomes after screening before or at age 3 years: follow up from randomised trial.

C Williams1, K Northstone, R A Harrad, J M Sparrow, I Harvey.   

Abstract

OBJECTIVE: To assess the effectiveness of early treatment for amblyopia in children.
DESIGN: Follow up of outcomes of treatment for amblyopia in a randomised controlled trial comparing intensive orthoptic screening at 8, 12, 18, 25, 31, and 37 months (intensive group) with orthoptic screening at 37 months only (control group).
SETTING: Avon, southwest England. PARTICIPANTS: 3490 children who were part of a birth cohort study. MAIN OUTCOME MEASURES: Prevalence of amblyopia and visual acuity of the worse seeing eye at 7.5 years of age.
RESULTS: Amblyopia at 7.5 years was less prevalent in the intensive group than in the control group (0.6% v 1.8%; P=0.02). Mean visual acuities in the worse seeing eye were better for children who had been treated for amblyopia in the intensive group than for similar children in the control group (0.15 v 0.26 LogMAR units; P<0.001). A higher proportion of the children who were treated for amblyopia had been seen in a hospital eye clinic before 3 years of age in the intensive group than in the control group (48% v 13%; P=0.0002).
CONCLUSIONS: The intensive screening protocol was associated with better acuity in the amblyopic eye and a lower prevalence of amblyopia at 7.5 years of age, in comparison with screening at 37 months only. These data support the hypothesis that early treatment for amblyopia leads to a better outcome than later treatment and may act as a stimulus for research into feasible screening programmes.

Entities:  

Mesh:

Year:  2002        PMID: 12089090      PMCID: PMC116606          DOI: 10.1136/bmj.324.7353.1549

Source DB:  PubMed          Journal:  BMJ        ISSN: 0959-8138


  27 in total

1.  Screening for refractive errors with the Topcon PR2000 Pediatric Refractometer.

Authors:  C Williams; R Lumb; I Harvey; J M Sparrow
Journal:  Invest Ophthalmol Vis Sci       Date:  2000-04       Impact factor: 4.799

2.  Screening for amblyopia in preschool children: results of a population-based, randomised controlled trial. ALSPAC Study Team. Avon Longitudinal Study of Pregnancy and Childhood.

Authors:  C Williams; R A Harrad; I Harvey; J M Sparrow
Journal:  Ophthalmic Epidemiol       Date:  2001-12       Impact factor: 1.648

3.  The amblyopia treatment study visual acuity testing protocol.

Authors:  J M Holmes; R W Beck; M X Repka; D A Leske; R T Kraker; R C Blair; P S Moke; E E Birch; R A Saunders; R W Hertle; G E Quinn; K A Simons; J M Miller
Journal:  Arch Ophthalmol       Date:  2001-09

4.  Inheritance of strabismus and the gain of using heredity to determine populations at risk of developing strabismus.

Authors:  M Abrahamsson; G Magnusson; J Sjöstrand
Journal:  Acta Ophthalmol Scand       Date:  1999-12

5.  New design principles for visual acuity letter charts.

Authors:  I L Bailey; J E Lovie
Journal:  Am J Optom Physiol Opt       Date:  1976-11

6.  Stereoacuity at age 3.5 y in children born full-term is associated with prenatal and postnatal dietary factors: a report from a population-based cohort study.

Authors:  C Williams; E E Birch; P M Emmett; K Northstone
Journal:  Am J Clin Nutr       Date:  2001-02       Impact factor: 7.045

7.  ALSPAC--the Avon Longitudinal Study of Parents and Children. I. Study methodology.

Authors:  J Golding; M Pembrey; R Jones
Journal:  Paediatr Perinat Epidemiol       Date:  2001-01       Impact factor: 3.980

8.  The period of susceptibility to the physiological effects of unilateral eye closure in kittens.

Authors:  D H Hubel; T N Wiesel
Journal:  J Physiol       Date:  1970-02       Impact factor: 5.182

9.  Interobserver agreement for grating acuity and letter acuity assessment in 1- to 5.5-year-olds with severe retinopathy of prematurity.

Authors:  E M Harvey; V Dobson; B Tung; G E Quinn; R J Hardy
Journal:  Invest Ophthalmol Vis Sci       Date:  1999-06       Impact factor: 4.799

10.  Early screening for amblyogenic risk factors lowers the prevalence and severity of amblyopia.

Authors:  M Eibschitz-Tsimhoni; T Friedman; J Naor; N Eibschitz; Z Friedman
Journal:  J AAPOS       Date:  2000-08       Impact factor: 1.220

View more
  45 in total

1.  Treatment of unilateral visual impairment on preschool vision screening: preschool vision screening should continue, perhaps earlier.

Authors:  Gerard O'Brien
Journal:  BMJ       Date:  2004-02-07

2.  Preschool vision screening.

Authors:  M J Moseley; A R Fielder
Journal:  Br J Ophthalmol       Date:  2003-08       Impact factor: 4.638

3.  Amblyopia treatment outcomes after preschool screening v school entry screening: observational data from a prospective cohort study.

Authors:  C Williams; K Northstone; R A Harrad; J M Sparrow; I Harvey
Journal:  Br J Ophthalmol       Date:  2003-08       Impact factor: 4.638

4.  Vision and hearing screening in school settings: Reducing barriers to children's achievement.

Authors:  Chengning Wang; Sarah Bovaird; Elizabeth Lee Ford-Jones; Rosalee Bender; Catherine Parsonage; Maria Yau; Bruce Ferguson
Journal:  Paediatr Child Health       Date:  2011-05       Impact factor: 2.253

Review 5.  Vision screening in preschool children: do the data support universal screening?

Authors:  Wolf A Lagrèze
Journal:  Dtsch Arztebl Int       Date:  2010-07-12       Impact factor: 5.594

6.  Electronic recording of occlusion treatment for amblyopia: potential of the new technology.

Authors:  Yaroslava Chopovska; Sjoukje E Loudon; Licia Cirina; Alina Zubcov; Huibert J Simonsz; Marc Lüchtenberg; Maria Fronius
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2004-12-17       Impact factor: 3.117

7.  Vision screening in infants, children and youth.

Authors: 
Journal:  Paediatr Child Health       Date:  2009-04       Impact factor: 2.253

Review 8.  Amblyopia.

Authors:  Stephanie West; Cathy Williams
Journal:  BMJ Clin Evid       Date:  2011-06-30

Review 9.  Amblyopia.

Authors:  Cathy Williams
Journal:  BMJ Clin Evid       Date:  2009-09-16

10.  Evaluation of 'vision screening' program for three to six-year-old children in the Republic of Iran.

Authors:  Rajiv Khandekar; Noa Parast; Ashraf Arabi
Journal:  Indian J Ophthalmol       Date:  2009 Nov-Dec       Impact factor: 1.848

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.